Search

7 May 2024: ONETEPOrder-N Electronic Total Energy Package. ONETEP (Order-N Electronic Total Energy Package) is a linear-scaling code for quantum-mechanical calculations based on density-functional theory.Licensing Options:. ONETEP is available on an academic

7 May 2024: ISOLDEBuilding High Quality Macromolecular Models into Low Resolution ExperimentalMaps. ISOLDE is a ChimeraX plugin (installable via its built-in Tool Shed) designed to ease the task ofbuilding high quality macromolecular models into low to medium

7 May 2024: StradviewStradview is a visualisation and analysis package for 3D imaging data. Stradview uses novel algorithms to produce:. High quality surface modelsVolume and surface based visualisations (including movies using scripts)Cortical bone

7 May 2024: Clari-FiClari-Fi uses blurring to simulate the challenges of viewing small icons, imagesand text on mobile screens. Ideas to Reality: Clari-Fi from Cambridge Enterprise on Vimeo. Clari-Fi helps to evaluate the visual clarity (i.e. perceptibility) of

7 May 2024: CamSol Method. Key Features:. Rational design of protein variants with enhanced solubility.Fast solubility screening of protein libraries.Identification of aggregation-promoting hotspots. The CamSol Method is available for commercial and academic

7 May 2024: KARPAS 299 Lymphoma Cell LineHuman Non-Hodgkin's Ki-positive Large Cell Lymphoma cell lines. KARPAS 299 Human Non-Hodgkin’s Ki-positive Large Cell Lymphoma cell line useful inoncology research, developed at the University of Cambridge. Cambridge

7 May 2024: CAM2 hearing aid fitting softwareCAM2 software is a package that enables hearing aids to be tailored to anindividual’s needs, resulting in improved hearing quality. All modern hearing aids include multi-channel amplitude compression and the

7 May 2024: KARPAS 417 Human Myeloma cell line. KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the Universityof Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. Wehave partnered

7 May 2024: KARPAS 929 Human Myeloma cell line. KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful inoncology research. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. Wehave partnered

7 May 2024: KARPAS 1272 Human Myeloma cell line. KARPAS 1272 Human Myeloma cell line useful in oncology research, developed at theUniversity of Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. Wehave

7 May 2024: KARPAS 707H Human Myeloma cell line. KARPAS 707H Human myeloma cell line suitable for the generation of stable humanhybridomas for the creation of fully human monoclonal antibodies. Cambridge Enterprise Limited is the exclusive licensor for the

7 May 2024: Human CD7 monoclonal antibody YTH30.15. Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are ratmonoclonal antibodies of the IgG2b isotype.

7 May 2024: Human CD59 monoclonal antibody YTH53.1. Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are ratmonoclonal antibodies of the IgG2b isotype. https://licensing.enterprise.cam.ac.uk/product/human-cd59-monoclonal-antibody

7 May 2024: Rat CD45 monoclonal antibody YTH 24.5. Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are ratmonoclonal antibodies of the IgG2b isotype. AuthorsHerman Waldmann. ReferencesC I Bindon, G Hale, M Clark, H

7 May 2024: Human CD11a monoclonal antibody YTH81.5. Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are ratmonoclonal antibodies of the IgG2a isotype.

7 May 2024: Mouse CD71 monoclonal antibody YTA74.4.4. Hybridoma cell line producing YTA 74.4.4 antibodies raised against mouse CD71 which aremonoclonal antibodies of the IgG2a isotype. Has been used in CD4 subset depletion in vivoand flow cytometry studies.

7 May 2024: Human CD28 monoclonal antibody YTH913.12. Hybridoma cell line producing YTH 913.12 antibodies raised against human CD28 which are ratmonoclonal antibodies of the IgG2b isotype.

7 May 2024: Human CD235a monoclonal antibody YTH89.1. Hybridoma cell line producing YTH 89.1 antibodies raised against human CD235a which are ratmonoclonal antibodies of the IgG2b isotype. AuthorsHerman Waldmann.

7 May 2024: Mouse CD18 monoclonal antibody YTS213.1.1. Hybridoma cell line producing YTS 213.1.1 antibodies raised against mouse CD18 which are ratmonoclonal antibodies of the IgG2a isotype. AuthorsHerman Waldmann.

7 May 2024: Rat IgG2b monoclonal antibody NORIg7.16.2. Hybridoma cell line against rat IgG2b, producing NORIg 7.16.2 antibodies which are mousemonoclonal antibodies. AuthorsHerman Waldmann. ReferencesG Hale; M Clark; H Waldmann(1 May